Close Menu

NEW YORK (GenomeWeb) – Bruker's board has authorized a share repurchase program, according to a document filed with the US Securities and Exchange Commission this week.

According to the firm's Form 8-K filed May 20, Bruker may repurchase shares of its common stock in order to offset the dilution of its stock resulting from the granting of option awards or restricted stock grants.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.